Literature DB >> 775253

Immunosuppressive agents in lupus nephritis: a critical analysis.

L Wagner.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 775253     DOI: 10.1097/00005792-197605000-00003

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.889


× No keyword cloud information.
  9 in total

Review 1.  Therapeutic aspects. Immunosuppression in established humoral responses.

Authors:  R F Gagnon; I C MacLennan
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1979

2.  The treatment of the nephritis of lupus erythematosus.

Authors: 
Journal:  West J Med       Date:  1977-06

3.  A review of glomerular ultrastructure in systemic lupus erythematosus.

Authors:  F R Comerford
Journal:  Ir J Med Sci       Date:  1977-07       Impact factor: 1.568

4.  Immunologic findings, thrombocytopenia and disease activity in lupus nephritis.

Authors:  W F Clark; A L Linton; P E Cordy; P E Keown; R C Lohmann; R M Lindsay
Journal:  Can Med Assoc J       Date:  1978-06-10       Impact factor: 8.262

5.  The effect of chronic daily cyclophosphamide administration on established antibody responses.

Authors:  R F Gagnon; I C MacLennan
Journal:  Clin Exp Immunol       Date:  1981-10       Impact factor: 4.330

6.  Monthly plasmapheresis for systemic lupus erythematosus with diffuse proliferative glomerulonephritis: a pilot study.

Authors:  W F Clark; R M Lindsay; D C Cattran; W B Chodirker; C C Barnes; A L Linton
Journal:  Can Med Assoc J       Date:  1981-07-15       Impact factor: 8.262

Review 7.  The treatment of lupus nephritis.

Authors:  J S Cameron
Journal:  Pediatr Nephrol       Date:  1989-07       Impact factor: 3.714

Review 8.  Lupus nephritis in childhood and adolescence.

Authors:  J S Cameron
Journal:  Pediatr Nephrol       Date:  1994-04       Impact factor: 3.714

9.  Systemic lupus erythematosus: Renal involvement and prognosis.

Authors:  B Silke; G D Doyle; E Campbell; O Brown; M Carmody; W F O'Dwyer
Journal:  Ir J Med Sci       Date:  1979-12       Impact factor: 1.568

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.